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Abstract
Background: Japanese encephalitis (JE) is the leading cause of viral encephalitis across Asia with approximately 70,000 cases
a year and 10,000 to 15,000 deaths. Because JE incidence varies widely over time, partly due to inter-annual climate
variability effects on mosquito vector abundance, it becomes more complex to assess the effects of a vaccination
programme since more or less climatically favourable years could also contribute to a change in incidence post-vaccination.
Therefore, the objective of this study was to quantify vaccination effect on confirmed Japanese encephalitis (JE) cases in
Sarawak, Malaysia after controlling for climate variability to better understand temporal dynamics of JE virus transmission
and control.
Methodology/principal findings: Monthly data on serologically confirmed JE cases were acquired from Sibu Hospital in
Sarawak from 1997 to 2006. JE vaccine coverage (non-vaccine years vs. vaccine years) and meteorological predictor
variables, including temperature, rainfall and the Southern Oscillation index (SOI) were tested for their association with JE
cases using Poisson time series analysis and controlling for seasonality and long-term trend. Over the 10-years surveillance
period, 133 confirmed JE cases were identified. There was an estimated 61% reduction in JE risk after the introduction of
vaccination, when no account is taken of the effects of climate. This reduction is only approximately 45% when the effects
of inter-annual variability in climate are controlled for in the model. The Poisson model indicated that rainfall (lag 1-month),
minimum temperature (lag 6-months) and SOI (lag 6-months) were positively associated with JE cases.
Conclusions/significance: This study provides the first improved estimate of JE reduction through vaccination by taking
account of climate inter-annual variability. Our analysis confirms that vaccination has substantially reduced JE risk in
Sarawak but this benefit may be overestimated if climate effects are ignored.
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Introduction
Japanese encephalitis (JE) is a mosquito-borne disease which is
the leading cause of viral encephalitis across Asia with approxi-
mately 70,000 cases a year and 10,000 to 15,000 deaths [1,2].
There are two transmission patterns of JEV in three climatic zones
[3,4]: in temperate climate zones such as such as Japan, Korea and
mainland China and Taiwan, and sub-tropical climate zones such
as Nepal, and northerly areas of India, Thailand and Vietnam,
JEV exhibits an epidemic or outbreak transmission pattern,
characterized by a well-defined seasonal peak. In tropical climate
zones such as Malaysia, Indonesia, southerly areas of Vietnam and
Thailand, JEV exhibits an endemic transmission characterized by
sporadic human cases throughout the year with seasonal peaks.
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Generally, it is considered that the prevailing transmission cycles
and the observed seasonality are a function of irrigation practices,
ambient temperature and bird migration patterns in different
regions [5].
Longitudinal investigations into the influence of temperature
and rainfall on the occurrence of serologically confirmed human
JE cases have been conducted in temperate environments with
epidemic JEV transmission, with studies generally showing that
high temperatures lead to high numbers of JE cases, while rainfall
associations are more variable [6–9]. To date no known parallel
studies have been undertaken in tropical countries with JEV-
endemic transmission. In addition, the influence El Nin˜o/La
Nin˜a-Southern Oscillation (ENSO), a major modifier of climate in
the tropics [10], on JEV transmission has received relatively little
attention [5] despite its impact on other members of the
Flavivirdae family, such as dengue [11–15]. Given that Malaysia,
Indonesia and most of the Philippines usually are the first to
experience ENSO-related impacts [16], investigation in these
areas is warranted.
JE incidence varies widely over time, partly because of inter-
annual climate variability effects on mosquito vector abundance.
This makes it more complex to assess the effects of a vaccination
programme because more or less climatically-favourable years
could also contribute to a change in incidence post-vaccination.
For example, a study in Taiwan looking at the association between
climate, vaccination rate and JE occurrence, only during the post-
vaccination period, found that the abundance of cases was still
under the influence of climate [8]. Furthermore, given the impact
of vaccination on confirmed JE cases, any association between JE
cases and meteorological variables may be masked by the
vaccination programme. Therefore, this study looks at Sarawak
Malaysia, a tropical environment with endemic JEV transmission,
during the pre- and post-vaccination period, with the objective of
determining the impact of JE vaccination after controlling for
meteorological variables and assessing the relationship between
meteorological variables and confirmed JE cases. We test the
hypotheses that: 1) temperature, rainfall and ENSO are associated
with confirmed JE cases in Sibu, Malaysia after controlling for
vaccination coverage year and 2) the estimated benefit of mass
vaccination is adjusted when account is taken of climate
conditions.
Material and Methods
Study area
All JE cases in this study originated from central Sarawak an
area with approximately 650,000 people (180,000 children #12
years). Sarawak has a generally stable equatorial climate that is hot
and humid throughout the year, with two monsoon seasons: a
northeast monsoon season with heavy rainfall occurring from
November to March and a southeast monsoon season with
relatively less rainfall occurring from May/June to September
[17]. All cases of encephalitis in the region are referred to Sibu
Hospital. With the introduction of the formalin-inactivated mouse
derived JE vaccine (Biken, Japan), a significant reduction in cases
has been observed [18,19].
Vaccine administration
The JE vaccine is provided for free under the Malaysian
National Immunisation Programme and the recommended JE
immunization interval schedule in Sarawak is: the primary series
at 9 and 10 months with subsequent booster at 18 months, 4.5, 8,
11 and 15 years; one injection of 0.5 mL is given at each interval
[19–21]. However, in practice we are reasonably certain that the
majority of children in our study received at least two doses of the
vaccine between 9 and 12 months.
Ethics statement
The original data collection of the study was approved by the
Director of Health for Sarawak and the Ethics Committee of the
Liverpool School of Tropical Medicine (Liverpool, UK). All data
analyzed were anonymized by removing any potential unique
identifiers before conducting the analysis. Informed consent was
obtained from each child’s parent or guardian before samples were
taken [18].
Data collection
The data on JE cases were obtained through a prospective study
in Sibu Hospital and a JE surveillance programme set up by the
Sarawak Health Department since 1997 [18,19]. Briefly, patients
with suspected JE were enrolled into the hospital-based surveil-
lance study. Paired sera and paired CSF for each patient were
considered to be the ideal specimen set. However, in reality the
complete specimen set was not obtained from many cases, from
whom we usually obtained a single serum and a CSF specimen.
Specimens were tested for JEV specific immunoglobulin-type M
by MAC-ELISA (Venture Technologies Sdn Bhd, Malaysia),
which distinguishes IgM elicited by JEV from that elicited by
dengue viruses [22,23]. The sensitivity, specificity, positive
predictive value and negative predictive value of the test used
were 83%, 99%, 0.98 and 0.92, respectively for CSF and 91%,
95%, 0.92 and 0.94, respectively for serum [23]. All cases of
encephalitis with specific IgM to JEV in serum and/or CSF were
considered to have been infected recently with JEV and classified
as confirmed JE cases. It is important to note that by the time a JE
infection leads to encephalitis there is usually no virus in the
periphery and thus a ‘‘confirmatory test’’ looking for evidence of
virus or virus genome is not useful.
Monthly mean, maximum, minimum and range temperature
(uC) and mean rainfall (cm/month) for central Sarawak was
acquired from the KNMI Climate Explorer [24] based on the
Climate Research Unit [25] dataset. The weather coverage
Author Summary
Japanese encephalitis (JE) virus is a mosquito-borne virus
which is the leading cause of viral encephalitis in Asia. The
cumulative attack rate for human JE cases is seemingly low
(2-cases/105/year); however, epidemics are focal and
intense, being concentrated in children 1 to 15 years of
age and highly clustered spatially. Despite the availability
of a vaccine against JE virus (JEV), a significant number of
JE cases still occur in Asia. Increases in disease cases may
occur in some countries, such as Indonesia and Bangla-
desh, due to increasing rice cultivation, pig husbandry and
lack of vaccination or vector control programs in these
areas. However, given the sensitivity of JEV transmission to
climate through impacts on the mosquito vectors, changes
in climate may increase or decrease JEV transmission.
Clearly, JE vaccination has substantially reduced JE cases,
but it is not clear if climate has any confounding impact on
our ability to estimate vaccine effect. We found that
approximately one quarter of the reduction in JE cases
since vaccination was introduced might be attributable to
climatically unfavourable years for the disease, rather than
the effect of vaccination. Vaccination studies involving
climate-sensitive diseases may be made more accurate by
taking climate effects into account.
Vaccine, Climate and JE in Malaysia
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window we used was latitude: 3.731–1.205u and longitude:
111.078–115.236u (see Supplemental Material, Figure S1). We
used the updated CRU TS 3.1 dataset (1901–2009) at 0.5u
(,55.5 km) spatial resolution [26]. The ENSO index used here is
the Southern Oscillation Index (SOI), air pressure difference
calculated between Tahiti and Darwin, Australia [27]. Monthly
SOI was acquired from the NOAA Climate Prediction Center
(CPC) [28] via KNMI Climate Explorer.
Statistical analysis
We fitted a Poisson log-linear regression model to the time series
of monthly incident counts using the R open source software
environment (www.r-project.org). We conducted the analysis in 3
phases:
Since it is well established that for JEV transmission there is a
lag effect of meteorological variables prior to initiation of pathogen
transmission [6–9], the initial phase in our analysis was to correlate
JE cases with climate variables and identify temporal lags. We
explored our data using Pearson’s correlation coefficient. Since
JEV transmission is thought to occur in Malaysia year-round in
epizootic cycles [5], we assessed lag times up to 12 months.
In the second phase of our study, the monthly number of
serologically confirmed JE cases was modelled using a Poisson
regression model. There was no over-dispersion in our analysis;
therefore, we found no need to set the scale parameter to a
Pearson x2 statistic. In our model, we adjusted for seasonality,
trend effects associated with JE cases and lag effects of the
meteorological variables, and used time series diagnostics (auto-
correlation of standardised residuals) to check the assumption of
uncorrelated residual variation.
We examined the relationships between the JE cases, vaccine,
meteorological variables and a linear time trend. Fourier terms up
to the second harmonic were included in the model to account for
seasonality in JE cases. An assumed full model that adjusts for the
effects of all the explanatory variables is:
log mtð Þ~b0zb1 cos vtð Þzb2 sin vtð Þz
b3 cos 2vptð Þzb4 sin 2vptð Þzb5tzbnXt
where v~2p=12 the annual periodicity in JE cases, t is an index of
time given as a sequence of numbers (i.e. 1,2,3…..n), Xt is some
covariate process (i.e. vaccine, temperature, rainfall and SOI) with
associated temporal lags.
To select and retain variables that significantly contributed to
the improvement of the model fit; we used a stepwise approach
using Akaike’s Information Criterion (AIC) as a measure of
relative goodness of fit, where smaller values represents better fits.
Risk ratios (RRs) derived from the estimated regression parameters
from the final model illustrate the associations between the
meteorological determinants and confirmed JE cases. We
attempted to identify statistical interactions with all combination
of seasonality, trend, vaccine coverage and meteorological
variables, but none of the combinations were significant. We also
determined the adjusted McFadden’s pseudo R2 given by:
1{
Fitted model deviance
Intercept only model deviance
n{1ð Þ n{k{1ð Þ
where n is the sample size and k is the number of parameters.
We used the monthly data from the 10-year surveillance period
in Sarawak from April 1997 to December 2006 where suspected
JE cases were serologically confirmed as JE positive or negative.
This dataset was used to test the association between JE cases,
vaccine and meteorological variables in Sarawak and develop our
model. We lagged vaccine coverage by two months to account for
the interval between the first and second vaccination. This made
clinical and immunological sense since the protection the vaccine
provides does not reach clinically acceptable protective efficacy
until the first two doses (given 1-month apart) are provided
(Centers for Disease Control and Prevention 1993). Though we
had three temperature variables (mean, maximum and minimum),
we only used minimum temperature in the final model since it had
the strongest fit and including mean and maximum temperature
would be redundant. Each lagged variable of SOI was individually
and iteratively assessed with temperature, rainfall and vaccine and
the final model was selected based on the models with lower AIC
value. We omitted the trend (i.e. timeindex) from the model
because the downward trend in JE cases over the 10-year study
period is likely attributed to the vaccination program. Also,
vaccine coverage year and trend (i.e. timeindex) were found to be
moderately correlated with each other (Pearson correlation
coefficient = 0.859, p,0.001); therefore, vaccine coverage year
was retained in the model, while trend was removed and not
considered further.
We developed two models: a vaccine only model (vaccine and
seasonality) and an observed climate and vaccine model (vaccine,
seasonality, minimum temperature, rainfall and SOI).
In the third and final phase, we used the observed climate and
vaccine model developed in the second analysis phase to predict
the number of JE cases that would have been seen if there was no
vaccine coverage throughout the 10-year surveillance and if there
was vaccine coverage throughout the 10-year surveillance period.
Vaccine effectiveness sensitivity analysis
We also conducted sensitivity analysis using different vaccine
effectiveness values from 0 to 100% to see the range in risk
reduction for different models. We used models with the variables:
i) vaccine only, and; ii) vaccine, minimum temperature, rainfall
and SOI. A study of children in Thailand vaccinated with two
doses of the formalin-inactivated mouse derived JEV vaccine
(Biken, Japan) showed that the vaccine had a 91% vaccine efficacy
[29,30] ; therefore, we assumed that the vaccine strategy being
used in Malaysia had at least a 91% effectiveness for the target
population, Sarawak children #12 years of age.
Results
JE cases
One-hundred-and-thirty-three serologically confirmed JE cases
were identified from April 1997 to December 2006 (10-year
period), 84 before and 49 after the vaccine period of July 2001.
There were relatively high levels of JEV transmission for four
seasons prior to the incorporation of JE vaccine into the expanded
programme of immunization (EPI) in the state of Sarawak in July
2001 (Figure 1A). After the vaccination program, JE cases dropped
substantially (Figure 1A). The majority of JE cases generally
occurred in the 4th quarter of the year (October to December)
(Figure 1B).
Correlation to JE cases
There was temporal variation in climate variables and JE cases
(see Supplemental Material, Figure S2). The mean, maximum and
minimum temperatures were correlated with JE cases at 5 to 7-
months lag; minimum temperature at 6-month lag showed the
strongest correlation with JE cases; and rainfall was only correlated
with JE cases at 1-month lag (see Supplemental Material, Table
S1).
Vaccine, Climate and JE in Malaysia
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We selected vaccine at 2-months lag, minimum temperature
at 6-months lag, rainfall a 1-month lag to be used in further
analysis since they provided a better fit than other variables and
lags (data not shown). Due to the persistence of the ENSO,
where its impact on climate [31], and subsequently disease risk
[32], can be felt for a whole year in the tropics, we iteratively
assessed up to 12 lags of SOI variables. SOI at 6-months lag
were used in the final model.
Poisson model fitting
Table 1 shows the association between vaccine at 2-months lag
and JE cases after controlling for seasonality (vaccine only model);
Table 2 shows the association between vaccine coverage at 2-
months lag, minimum temperature at 6-months lag, rainfall at 1-
month lag, and SOI at lag 6-month lag, and JE cases after
controlling for seasonality (observed climate and vaccine model).
All variables were significantly associated with JE cases in the
different models. The observed climate and vaccine model had a
higher adjusted pseudo-R2 and lower Akaike information
criterion (AIC= 300.196, adjusted pseudo-R2 = 0.377) than the
vaccine only model (Akaike information criterion = 317.398,
adjusted pseudo-R2 = 0.278) suggesting the former is a ‘‘better’’
model. There was no significant autocorrelation in JE cases.
Trend was not significant when included in the model with
vaccine.
No interaction effects amongst the meteorological variables or
vaccine variable were observed in our model suggesting no
differential response of JE cases to the aforementioned variables.
For the vaccine only model, there seems to be an approximately
61% decrease in JE cases after the implementation vaccination
programme (post July 2001) relative to prior the implementation
(pre July 2001). In contrast, for the observed climate and vaccine
models, the estimated decrease is approximately 45%.
The observed climate and vaccine models also suggest that a 1-
unit increase in minimum temperature at a 6-month lag, rainfall at
1-month lag, and SOI at 6-month lag may be associated with
approximately 100% (2-fold), 3% and 40% increases in risk of JE
in Sarawak respectively. To better understand the effect of the
scale of variability in temperature, rainfall and SOI on JE cases we
also calculated the relative risk using the difference between the
lower and upper quartiles of the explanatory variable. There was
on average a 41%, 53% and 66% increase in JE risk for the upper-
lower quartile difference for temperature, rainfall and SOI,
respectively (see Supplemental Material, Table S2).
The observed climate and vaccine model performed relatively
well with a pseudo-R2 value of 0.370 suggesting an improvement
37.0% in the fitted model from the null (intercept only) model
(Figure 2). Autocorrelation tests undertaken on the residuals of the
fitted model to determine the goodness-of-fit showed no significant
autocorrelation at different lags (see Supplemental Material,
Figure S3).
Figure 1. Time series (A) and seasonality (B) of confirmed Japanese Encephalitis cases from Sarawak, Malaysia from April 1997 to
December 2006.
doi:10.1371/journal.pntd.0002334.g001
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Prediction of JE cases without and with JE vaccination
Table 3 shows the sum of the observed and predicted JE cases
modelled with and without vaccination over the 10-year surveil-
lance period. The observed and predicted JE case sums were
similar with the model slightly over-predicting the pre-vaccine
period and under predicting the post-vaccine period and the total.
When the model assumed no vaccine coverage over the 10-year
surveillance period, 175 JE cases were predicted; when the model
assumed vaccine coverage throughout the 10-year surveillance
period, only 90 cases were predicted (Table 3). Figure 3 shows the
time series of observed and predicted JE cases modelled with and
without vaccination over the 10-year surveillance period.
Vaccine effectiveness sensitivity analysis
Figure 4 shows the JE risk reduction at different vaccine
efficacies (VE) for the vaccine only model and observed climate
and vaccine model. In the vaccine only model, the sensitivity
analysis shows that ranges in the risk reduction of JE cases due to
the vaccine programme is approximately between 45 and 65% for
vaccine efficacies ranging between 60 and 100% under the current
vaccine strategy in Sarawak. However, the observed climate and
vaccine model shows a lower risk reduction of JE cases due to the
vaccine programme. The observed climate and vaccine model
with SOI shows a risk reduction of approximately 30 to 45% for
vaccine efficacies ranging between 60 and 100%.
Table 2. Multivariable estimate of the JE risk ratio for vaccine coverage year, different weather variables and Southern Oscillation
Index (SOI), controlling for seasonal periodicity using Poisson regression.
Variables RR/b (95% CI of RR) Std. Error p-valuea
Vaccine year (Jul 01–Dec 06) at 2-month lag 0.548b (0.368, 0.818) 0.2039 0.003
Non-vaccine year (Apr 97–Jun 01) at 2-month lag 1c . .
Minimum temperature (6C) at 6-months lag 2.016b (1.269, 3.204) 0.2363 0.003
Rainfall (cm/month) at 1-month lag 1.027b (1.007, 1.047) 0.0099 0.007
SOI at 6-months lag 1.404b (1.147, 1.718) 0.1031 0.001
cos12 20.311d 0.1558 0.046
cos6 20.183d 0.1324 0.167
sin12 20.213d 0.1596 0.181
sin6 0.239d 0.1402 0.088
Intercept 215.422d 5.0538 0.002
RR = risk ratio;
aBased on Wald chi-square test;
bRisk Ratio;
cReference.
db-value.
Akaike information criterion = 300.196, Adjusted Pseudo-R2 = 0.377. cos12 and sin12 models annual periodicity; cos6 and sin6 models biannual periodicity. Pseudo- R2 is
based on 1 minus the deviance ratio between the full model vs. the Intercept only model adjusting for the number of explanatory terms in a model (1 – (Full model DEV/
Intercept only model DEV) * ((n-1)/(n-k-1))), where n is the sample size and k is the number of explanatory terms.
doi:10.1371/journal.pntd.0002334.t002
Table 1. Multivariable estimate of JE risk ratio for vaccine coverage year, controlling for seasonal periodicity using Poisson
regression.
Variables RR/b (95% CI of RR) Std. Error p-valuea
Vaccine year (Jul 01–Dec 06) at 2-month lag 0.391b (0.273, 0.560) 0.1838 ,0.001
Non-vaccine year (Apr 97–Jun 01) at 2-month lag 1c . .
cos12 20.288d 0.1420 0.043
cos6 20.190d 0.1313 0.148
sin12 20.500d 0.1297 ,0.001
sin6 0.391d 0.1313 0.003
Intercept 0.398d 0.1142 ,0.001
RR = risk ratio;
aBased on Wald chi-square test;
bRisk Ratio;
cReference.
db-value.
Akaike information criterion = 317.398, Adjusted Pseudo-R2 = 0.278. cos12 and sin12 models annual periodicity; cos6 and sin6 models biannual periodicity. Pseudo- R2 is
based on 1 minus the deviance ratio between the full model vs. the Intercept only model adjusting for the number of explanatory terms in a model (1 – (Full model DEV/
Intercept only model DEV) * ((n-1)/(n-k-1))), where n is the sample size and k is the number of explanatory terms.
doi:10.1371/journal.pntd.0002334.t001
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Discussion
This study is the first to use laboratory-confirmed human JE
cases to investigate the impact of vaccine, climate and ENSO on
JEV transmission in Sarawak, Malaysia, a JEV endemic area. We
provided an improved estimate of the reduction in JE cases in
Sarawak, Malaysia after the introduction of the JE vaccine into the
national child vaccination program, by taking account of climate
inter-annual variability. We also investigated the association
between meteorological variables and JE cases in the presence of
vaccine coverage as well as assessing statistical interaction and
confounding among the variables.
Wong et al (2008) and Ooi et al (2008) fully describe the
demographic characteristics of the patients pre- and post-
vaccination [18,19]. Briefly, one hundred and twenty-two (92%)
patients were children aged 12 years and younger, 11 (8%) patients
were older children and adults. After vaccination, the mean age
(range) of all affected patients shifted from 7.0 to 9.2 years. This
shift in age distribution has also occurred in other countries where
JE vaccine was introduced, namely in Japan, Korea, China and
Taiwan [33]. When we consider the study of Wong et al 2008 who
looked at JE cases before and after the vaccination program, they
report a 56% drop in JE cases in children #12 years of age over
the 6-year period after the implementation of the vaccination
programme (Non-vaccine years: 9.8 cases/105/year vs. Vaccine
years: 4.3 cases/105/year) in July 2001; however, they also
suggested that a ‘catch-up’ program was required since older
children and teenagers were not included in the current
vaccination programme [19]. The model developed in this study
may be useful for temporally targeting this population.
Because the magnitude of vector-borne disease outbreaks are
often regulated by climate, due to sensitivities of the vector to
temperature, humidity and rainfall, the impact of vaccination
programmes on disease risk reduction must be evaluated carefully.
There was a difference in the magnitude of risk reduction in JE
cases due the vaccination programme in vaccine only model (RR:
0.391) and the observed climate and vaccine models (RR: 0.548).
This study may be useful to other JE-endemic countries that have
not implemented JE vaccination programmes and have increasing
trend in JE incidence such as Indonesia, Cambodia, and
Bangladesh [34] or are in the early stages of their vaccination
programme such as India [35]. Given climate change, these
countries should consider what will be the true impact of their
vaccination programme. Furthermore, because vaccine efficacy
can be influenced by various operational issues [36], we assessed a
range of vaccine efficacy estimates to determine the array of JE
Figure 2. Observed versus predicted JE cases for observed climate and vaccine model (vaccine, seasonality, temperature, rainfall
and SOI): time series (A); the vertical grey dotted line represents the introduction of the JE vaccine into the National Immunization program in
Sarawak, Malaysia in July 2001 and scatter plot (B) of predicted versus observed values of JE cases; diagonal line represent the trend through all data
points during the non-vaccine and vaccine years. Model fitted using Poisson regression.
doi:10.1371/journal.pntd.0002334.g002
Table 3. Sum of observed and predicted Japanese encephalitis cases modeled with and without vaccination over the 10-year
surveillance period.
Modeled
Vaccine coverage
Observed
JE cases
Predicted
JE cases1
Predicted JE cases
with no vaccine2
Predicted JE
cases with vaccine3
Pre-vaccine (Apr-97–Jun-01) 84 87 87 48
Post-vaccine (Jul-01–Dec-06) 49 43 88 42
Total 133 130 175 90
1Predicted JE cases are predictions where the vaccine regime was as observed.
2Predicted JE cases with no vaccine assume no vaccine over the entire 10-years period.
3Predicted JE cases with vaccine assume vaccine usage over the entire 10-years period.
doi:10.1371/journal.pntd.0002334.t003
Vaccine, Climate and JE in Malaysia
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Figure 4. Japanese encephalitis risk reduction at different vaccine efficacies (VE) for the vaccine only model (vaccine, seasonality
and no weather variables), and the observed climate and vaccine model (vaccine, seasonality, temperature, rainfall and SOI).
doi:10.1371/journal.pntd.0002334.g004
Figure 3. Observed versus predicted JE cases (A) without and (B) with vaccine coverage over the 10-year surveillance period: the
vertical grey dotted line represents the introduction of the JE vaccine into the National Immunization program in Sarawak, Malaysia in July 2001. A–
Predicted JE cases modelled without vaccine coverage over the 10-year period, minimum temperature at 6-months lag, rainfall at 1-month lag, SOI at
6-months lag and modelled seasonality. B– Predicted JE cases modelled with vaccine coverage throughout the 10-year surveillance period, minimum
temperature at 6-months lag, rainfall at 1-month lag, SOI at 6-months lag and modelled seasonality).
doi:10.1371/journal.pntd.0002334.g003
Vaccine, Climate and JE in Malaysia
PLOS Neglected Tropical Diseases | www.plosntds.org 7 August 2013 | Volume 7 | Issue 8 | e2334
case reductions that could be achieved. We found that even a 60%
vaccine efficacy would result in greater than 30% risk reduction in
JE cases in Sarawak after controlling for climate. This analysis
shows the robustness of JE vaccination even in the face of climate.
Therefore, taking full account of climate, the effect of the current
Malaysian vaccine strategy is to reduce cases by approximately
50% (i.e. 88 saved out of 175).
Vaccine coverage, minimum temperature, rainfall, and SOI
provided the best fit to JE case data. Surprisingly, we found the 6-
month lag time between minimum temperature and JE cases to be
highly significant, and this is consistent with some other studies
that report 6-month lags. However, the full biological basis is
unclear as it exceeds the lifespan of the vector. On the other hand,
this statistical result does not imply causality. It may be
confounded with other temperature variables at different lags
which have direct biological effects. Still, JEV is transmitted year-
round in Malaysia; such lag times may indeed describe the
transmission pattern in the region.
SOI at 6-month lag had a strong positive association with JE
cases and in our model. It is important to note that an increasing
SOI would suggest a tendency towards a La Nin˜a phase
(prolonged long-term cooling in Pacific Ocean surface tempera-
tures) while a decreasing SOI would suggest a tendency towards El
Nin˜o phase (prolonged long-term warming in Pacific Ocean sea
surface temperatures). In 1997–1998, the largest El Nin˜o event
was observed. This was followed in 1998–2000, by a strong La
Nin˜a phase. El Nin˜o phases are generally associated with warmer
and drier than average climatic conditions, while La Nin˜a phases
are related to cooler and wetter climate conditions in Malaysia
[37]. During the same period, there was a slightly higher level of
reporting of JE in Sarawak, Malaysia during the high transmission
peak of August to December.
Given our results on the impact of temperature, rainfall and
SOI, on the occurrence of JE cases, further study would be useful
to determine how they shape JEV transmission in Malaysia.
The four major limitation of this study were 1) highly focused
and small scale nature of the original pilot hospital-based
surveillance study, which only used a single hospital and a passive
surveillance method; 2) the reporting bias from the relatively
higher peak of JE cases in Sarawak in 1998, which also coincided
with the Nipah virus outbreak in Malaysia and led to greater effort
to accurately identify encephalitic cases relative to the other years;
3) a very limited time series (i.e. 10 years) during which there was
only one relatively large JE outbreak peak, only 3 ENSO events (2
El Nin˜o and 1 La Nin˜a) and only 4 years when there was no
vaccine; and 4) because West Nile (Kunjin) virus has been isolated
from mosquitoes in Sarawak [38] patients may have been
misdiagnosed due to cross-reactivity between West Nile virus
(WN) virus (WNV) and JEV. Because we focused on a single
hospital in Sarawak, which was the main referral hospital in the
area, and collected accurate data, we are confident we have a less
biased sample that is providing a lucid picture of JEV infection
trends. A study demonstrated the high peak in 1998 during the
Nipah outbreak was for the whole Sarawak state, while the peak
for Sibu during the same period was not substantially different
from the other years [19], suggesting that the data collected for
Sibu are less prone to clinician awareness bias since even the
heightened reporting for encephalitis cases in 1998/1999 did not
change the reporting pattern in Sibu. With such a short time
period and the reduction of disease cases with vaccination, it is
difficult to say with certainty whether the patterns seen in the study
are regular predictable phenomena or random events; therefore,
longer studies with pig or mosquito JE incidence may be useful in
future studies. Whilst the serological tests employed in the study
were able to distinguish infections caused by dengue virus from
JEV, it cannot do so for infections caused by WNV. Because of this
limitation, we have conducted a limited serological study for WNV
infection in patients who presented with acute encephalitis
syndrome and found no evidence of West Nile infection in the
patient group (unpublished data).
Conclusion
Minimum temperature, rainfall and SOI were the key
meteorological determinants associated with JE cases in Sarawak.
These variables may be useful for developing an early-warning
system based on seasonal climatic forecasting to temporally target
vaccination programs to reduce the associated cost of vaccine
distribution as well as scaling-up the current vaccine strategy to
include un-prioritized or underserved populations. However, the
mechanisms by which these variables impact JEV transmission is
not entirely clear and require further investigation for develop-
ment of a potential forecast system. For diseases like JE,
vaccination for mitigation of disease cases should always be a
top priority. However, to increase estimation accuracy of the
vaccine effect, climate should be considered in epidemiological
vaccine evaluations to determine the un-confounded impact of
vaccination programs.
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